EXPONENT INC
Price data unavailable
Track EXPO in your trading journalAbout EXPONENT INC
EXPONENT INC (EXPO) is a publicly listed company on US equity markets.
Exponent Inc is a science and engineering consulting firm that provides solutions to complex problems. The company's consultant team is composed of scientists, physicians, engineers, as well as business and regulatory consultants. The company currently operates through two segments. The engineering and other scientific segments, which account for the majority of revenue, provide servicing encompassing biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, etc. The environmental and health segment covers chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences and others. The company generates almost all of its revenues from America.
The company reports trailing twelve-month revenue of $582.01M and net income of $29.57M.
Key metrics include a return on equity of 8.7%, a debt-to-equity ratio of 1.03.
Use FINOTAUR to track EXPO's price action, review fundamentals, and stay current with company news — all in one research dashboard.
Fundamentals
| Revenue (TTM) | $582.01M |
| Net Income (TTM) | $29.57M |
| EPS (TTM) | — |
| P/E Ratio | — |
| Return on Equity | 8.74% |
| Debt-to-Equity | 1.03 |
| Dividend per Share | — |
Recent News
- GlobeNewswire Inc.·Apr 6
Exponent Elevates John Pye to President and Eric Anderson to CFO Reporting to Catherine Corrigan, CEO; Rich Schlenker to Remain as Executive VP and to Stand for Election to Board of Directors
- Benzinga·Feb 5
Exponent Reports Fourth Quarter and Fiscal Year 2025 Financial Results
- Benzinga·Feb 5
Exponent Increases Quarterly Dividend Payment from $0.30 to $0.31 per Share for Q1 2026
Want real-time analysis on EXPO?
Track it free in your trading journal. Log trades, tag setups, and review your edge.